The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Resveratrol: One molecule, many targets
Abstract
Resveratrol is one of the numerous polyphenolic compounds found in several vegetal sources. In recent years, the interest in this molecule has increased exponentially following the major findings that resveratrol (i) is shown to be chemopreventive in some cancer models, (ii) is cardioprotective, and (iii) has positive effects on several aspects of metabolism, leading to increased lifespan in all the metazoan models tested thus far, including small mammals. Such remarkable properties have elicited a vast interest towards the identification of target proteins of resveratrol and have led to the identification of enzymes inhibited by resveratrol and others whose activation is enhanced. In the vast majority of cases, resveratrol displays inhibitory/activatory effects in the micromolar range, which is potentially attainable pharmacologically, although targets with affinities in the nanomolar range have also been reported. Here, we provide an overview of the various classes of enzymes known to be inhibited (or activated) by resveratrol. It appears that resveratrol, as a pharmacological agent, has a wide spectrum of targets. The biological activities of resveratrol may thus be dependent on its simultaneous activity on multiple molecular targets. © 2008 IUBMB IUBMB Life, 60(5): 323–332, 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 5×
“Also, both tumour number and incidence in a mouse skin model of tumorigenesis were effectively decreased by topic application of 25 lM resveratrol twice a week (5).”
InfluentialResveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., & Takada, Y. (2004) · PubMed · Cited by 1,395
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,197
Crystal structure of the Src family tyrosine kinase Hck
Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,172
Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,165
Mechanism of Human SIRT1 Activation by Resveratrol
Borra, M. T., Smith, B. C., & Denu, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501250200 · Cited by 1,065
Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0022 · Cited by 824
Calorie restriction–the SIR2 connection
Guarente, L., & Picard, F. (2005) · Cell · doi:10.1016/j.cell.2005.01.029 · Cited by 793
Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., & Dannenberg, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21875 · Cited by 786
Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., & Cellerino, A. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.038 · Cited by 784
SIRT1 Improves Insulin Sensitivity under Insulin-Resistant Conditions by Repressing PTP1B
Sun, C., Zhang, F., Ge, X., Yan, T., Chen, X., Shi, X., & Zhai, Q. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.014 · Cited by 766
Speakman, J. R., Talbot, D. A., Selman, C., Snart, S., McLaren, J. S., Redman, P., Krol, E., Jackson, D. M., Johnson, M. S., & Brand, M. D. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00097.x · Cited by 761
Substrate-specific activation of sirtuins by resveratrol
Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., Napper, A., Curtis, R., DiStefano, P. S., Fields, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500655200 · Cited by 745
Zang, M., Xu, S., Maitland-Toolan, K. A., Zuccollo, A., Hou, X., Jiang, B., Wierzbicki, M., Verbeuren, T. J., & Cohen, R. A. (2006) · Diabetes · doi:10.2337/db05-1188 · Cited by 664
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
Subbaramaiah, K., & Dannenberg, A. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00043-3 · Cited by 649
Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons
Parker, J. A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., & Néri, C. (2005) · Nature Genetics · doi:10.1038/ng1534 · Cited by 512
Stivala, L. A., Savio, M., Carafoli, F., Perucca, P., Bianchi, L., Maga, G., Forti, L., Pagnoni, U. M., Albini, A., Prosperi, E., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101846200 · Cited by 492
Sirtuins as potential targets for metabolic syndrome
Guarente, L. (2006) · Nature · doi:10.1038/nature05486 · Cited by 468
How does calorie restriction work?
Koubova, J., & Guarente, L. (2003) · Genes & Development · doi:10.1101/gad.1052903 · Cited by 453
Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans
Bass, T. M., Weinkove, D., Houthoofd, K., Gems, D., & Partridge, L. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.07.007 · Cited by 435
Kopp, P. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380619 · Cited by 392
Resveratrol, a remarkable inhibitor of ribonucleotide reductase
Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., & Guittet, O. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01572-x · Cited by 383
Srivastava, R. K., Srivastava, A. R., Korsmeyer, S. J., Nesterova, M., Cho-Chung, Y. S., & Longo, D. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3509 · Cited by 365
Myers, M. G., Sun, X. J., & White, M. F. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90007-8 · Cited by 315
Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K., Khaled, A., Zervos, A. S., Carter, B., Turkson, J., & Jove, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0268 · Cited by 283
Effects of stilbenes on arachidonate metabolism in leukocytes
Yoshiyuki, K., Hiromichi, O., & Shigeru, A. (1985) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(85)90167-5 · Cited by 273
Kundu, J. K., Shin, Y. K., Kim, S. H., & Surh, Y.-J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi349 · Cited by 271
DNA Polymerase and Topoisomerase II Inhibitors from Psoraleacorylifolia
Sun, N. J., Woo, S. H., Cassady, J. M., & Snapka, R. M. (1998) · Journal of Natural Products · doi:10.1021/np970488q · Cited by 262
Resveratrol is a Peroxidase-mediated Inactivator of COX-1 but Not COX-2
Szewczuk, L. M., Forti, L., Stivala, L. A., & Penning, T. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314302200 · Cited by 240
Park, C. E., Kim, M.-J., Lee, J. H., Min, B.-I., Bae, H., Choe, W., Kim, S.-S., & Ha, J. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.25 · Cited by 239
Resveratrol increases vascular oxidative stress resistance
Ungvari, Z., Orosz, Z., Rivera, A., Labinskyy, N., Xiangmin, Z., Olson, S., Podlutsky, A., & Csiszar, A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01258.2006 · Cited by 237
Crystal Structure of Quinone Reductase 2 in Complex with Resveratrol,
Buryanovskyy, L., Fu, Y., Boyd, M., Ma, Y., Hsieh, T.-C., Wu, J. M., & Zhang, Z. (2004) · Biochemistry · doi:10.1021/bi049162o · Cited by 236
Bauer, J. H., Goupil, S., Garber, G. B., & Helfand, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403493101 · Cited by 234
Kinase Inhibitors from Polygonum cuspidatum
Jayatilake, G. S., Jayasuriya, H., Lee, E.-S., Koonchanok, N. M., Geahlen, R. L., Ashendel, C. L., McLaughlin, J. L., & Chang, C.-J. (1993) · Journal of Natural Products · doi:10.1021/np50100a021 · Cited by 233
Aziz, M. H., Nihal, M., Fu, V. X., Jarrard, D. F., & Ahmad, N. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0526 · Cited by 201
The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs
Matter, W. F., Brown, R. F., & Vlahos, C. J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90792-j · Cited by 196
Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity
Maccarrone, M., Lorenzon, T., Guerrieri, P., & Agrò, A. F. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00630.x · Cited by 195
Kundu, J. K., Shin, Y. K., & Surh, Y.-J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.005 · Cited by 193
SIR2: a potential target for calorie restriction mimetics
Chen, D., & Guarente, L. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.004 · Cited by 185
Yang, T., Fu, M., Pestell, R., & Sauve, A. A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.04.002 · Cited by 183
Genes determining yeast replicative life span in a long-lived genetic background
Kaeberlein, M., Kirkland, K. T., Fields, S., & Kennedy, B. K. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.10.007 · Cited by 171
Resveratrol and breast cancer chemoprevention: Molecular mechanisms
Le Corre, L., Chalabi, N., Delort, L., Bignon, Y.-J., & Bernard-Gallon, D. J. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400094 · Cited by 161
Resveratrol is a class IA phosphoinositide 3-kinase inhibitor
Fröjdö, S., Cozzone, D., Vidal, H., & Pirola, L. (2007) · Biochemical Journal · doi:10.1042/bj20070236 · Cited by 158
Self-citationAMP‐activated protein kinase and muscle glucose uptake
Musi, N., & Goodyear, L. J. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01168.x · Cited by 152
El‐Mowafy, A. M., & White, R. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00541-4 · Cited by 132
Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells
Sexton, É., Themsche, C. V., Leblanc, K., Parent, S., Lemoine, P., & Asselin, É. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-45 · Cited by 131
MIZUTANI, K., Ikeda, K., Kawai, Y., & Yamori, Y. (2000) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.46.78 · Cited by 125
The Red Wine Polyphenol Resveratrol Displays Bilevel Inhibition on Aromatase in Breast Cancer Cells
Wang, Y., Lee, K. W., Chan, F. L., Chen, S., & Leung, L. K. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj190 · Cited by 125
Effect of resveratrol on the development of spontaneous mammary tumors in HER‐2/neu transgenic mice
Provinciali, M., Re, F., Donnini, A., Orlando, F., Bartozzi, B., Stasio, G. D., & Smorlesi, A. (2005) · International Journal of Cancer · doi:10.1002/ijc.20874 · Cited by 124
Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells
Cecchinato, V., Chiaramonte, R., Nizzardo, M., Cristofaro, B., Basile, A., Sherbet, G. V., & Comi, P. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.001 · Cited by 117
El‐Mowafy, A. M. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg015 · Cited by 117
Resveratrol inhibits insulin responses in a SirT1-independent pathway
Zhang, J. (2006) · Biochemical Journal · doi:10.1042/bj20050977 · Cited by 115
Inhibition of protein kinase C by resveratrol
Slater, S. J., Seiz, J. L., Cook, A. C., Stagliano, B. A., & Buzas, C. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00214-4 · Cited by 113
Long, D. J., Iskander, K. S., Gaikwad, A. S., Arin, M. J., Roop, D. R., Knox, R. J., Barrios, R. J., & Jaiswal, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208675200 · Cited by 110
Design and synthesis of compounds that extend yeast replicative lifespan
Yang, H., Baur, J. A., Chen, A. Y., Miller, C. M., & Sinclair, D. A. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00259.x · Cited by 108
Atten, M. J., Godoy-Romero, E., Attar, B. M., Milson, T., Zopel, M., & Holian, O. (2005) · Investigational New Drugs · doi:10.1007/s10637-005-5855-8 · Cited by 106
Stewart, J. R., Ward, N. E., Ioannides, C. G., & O’Brian, C. A. (1999) · Biochemistry · doi:10.1021/bi990875u · Cited by 97
Stewart, J. R., & O’Brian, C. A. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000011787.75522.ec · Cited by 86
Das, S., Tósaki, Á., Bagchi, D., Maulik, N., & Das, D. K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095133 · Cited by 77
Wang, Z., Hsieh, T., Zhang, Z., Ma, Y., & WU, J. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.174 · Cited by 75
Does resveratrol activate yeast Sir2 in vivo?
Kaeberlein, M. R., & Kennedy, B. K. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00314.x · Cited by 22
Pharmacological concentration of resveratrol suppresses aromatase in JEG-3 cells
Wang, Y., & Leung, L. K. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.07.009 · Cited by 21
Zhou, Y., Zhang, F., Abidi, P., Lin, M., Thiel, G., & Liu, J. (2006) · Biochemical Journal · doi:10.1042/bj20060044 · Cited by 8
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Plant Polyphenols as Dietary Antioxidants in Human Health and Disease
Pandey, K. B., & Rizvi, S. I. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9498 · Cited by 3,942
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Sun, W., & Shahrajabian, M. H. (2023) · Molecules · doi:10.3390/molecules28041845 · Cited by 806
Anti-Inflammatory Action and Mechanisms of Resveratrol
Meng, T., Xiao, D., Muhammed, A., Deng, J., Chen, L., & He, J. (2021) · Molecules · doi:10.3390/molecules26010229 · Cited by 698
Metadata
- Authors
- Pirola, L., & Fröjdö, S.
- Venue
- IUBMB Life
- Publisher
- Wiley
- Published
- 2008-04-17
- Volume
- 60
- Issue
- 5
- Pages
- 323-332
- ISSN
- 1521-6543 (ISSN-L)
- 1521-6551
- OpenAlex
- W2135664206
- Cited by
- 347
- References
- 75
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.